| Jul 24 |
PBMs battle bipartisan scrutiny as lawmakers eye industry reform
|
| Jul 23 |
Invest $50K in CVS Health and Gilead Sciences to Become a Dividend Millionaire
|
| Jul 23 |
CVS Caremark® defines future of pharmacy benefit management
|
| Jul 23 |
Drug Middlemen Push Patients to Pricier Medicines, House Probe Finds
|
| Jul 20 |
Possible Bearish Signals With CVS Health Insiders Disposing Stock
|
| Jul 19 |
CVS Health (CVS) Stock Moves -0.57%: What You Should Know
|
| Jul 19 |
Boehringer Ingelheim offers Humira biosimilar at 92% discount
|
| Jul 18 |
Healthcare stocks at an 'inflection point,' analyst says
|
| Jul 17 |
Top PBM execs to testify before House Oversight Committee
|
| Jul 15 |
Positive week for CVS Health Corporation (NYSE:CVS) institutional investors who lost 14% over the past year
|
